Angiology: Open Access
Open Access

Abstract

Interest of Streptokinase Thrombolysis in Pulmonary Embolism with High Risk of Mortality: Case of the Cardiology Department of the National Ignace Deen Teaching Hospital in Conakry

Baldé Elhadj Yaya, Barry Ibrahima Sory, Camara Ousmane Mamadama*, Bah Abdoulaye, Keita Fatoumta Binta, Touré Abdoulaye, Tounkara Ibrahima Kalil, Kaba Abdoul Karim, Diallo souleymane M’Bara, Beavogui Mariame and Baldé Mamadou Dadhi

Pulmonary embolism is a potentially fatal and common complication of venous thromboembolism. Its serious form due to alteration of the hemodynamic state requires emergency treatment by thrombolysis. Through this study, we aim to evaluate the benefit of streptokinase thrombolysis in the management of pulmonary embolism with a high risk of mortality in the Cardiology department of the Ignace Deen national hospital in Conakry. We conducted a retrospective descriptive study over a period of 2 years (1 August, 2021 to 31 August, 2023) focusing on patients hospitalized for pulmonary embolism with severity criteria. The morbidity of pulmonary embolism with high mortality risk according to our study was 12.8%. The average age of our patients was 67 ± 34 years with a male predominance of 70%. The main clinical manifestations were chest pain (63.5%) and dyspnea (75%). All patients (100%) had undergone chest CT angiography for diagnostic confirmation. Thrombolysis was carried out using streptokinase in all our patients (100%). Tolerance of treatment was good without signs of hemorrhage in all patients (100%). Streptokinase thrombolysis proves to be a considerable therapeutic alternative in the management of serious pulmonary embolism in our context.

Published Date: 2025-01-17; Received Date: 2024-12-17